Avalon GloboCare Corp. Common Stock (ALBT)

FairStock Score: 27/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for understandable businesses with durable competitive advantages and a margin of safety. Avalon GloboCare does not clear those tests. It describes AI platforms, cellular therapy, and consumer health devices, but it is a $3.3 million market-cap company with only two employees. At the 2026-08-31 close of $2.87, the market is pricing a story, not proven value. In the 2025 fourth quarter, revenue was negative $1.1 million and net income was negative $2.1 million, with a reported margin of 196.70%. A company reporting negative revenue is not a stable enterprise; that suggests reversals, discontinued operations, or accounting distortions, none of which builds a moat. FairStock calculates a trailing free cash flow of negative $6.0 million and a free-cash-flow yield of negative 179.4%. That means the business is consuming cash at a rate far larger than its entire market value. The FairStock ratios are equally grim: P/E of -0.62, ROE of -501.20%, ROCE of -39.69%, Piotroski F-score of 1/9, and Altman Z-score of -11.09. The debt-to-equity ratio of 0.12 is one small positive, but low leverage does not fix negative cash flow. The stock also has no Peter Lynch category because there are zero years of filed results, when at least three are needed. Its 52-week range of $0.21 to $4.72 suggests speculation dominates. Without consistent revenue, positive cash flow, or an asset-backed margin of safety, I see no durable franchise here - only a speculative vehicle.

In plain English: Avalon GloboCare is a very small company that says it works on AI software, health technology, and a breath-testing device. The latest figures look weak: in the 2025 fourth quarter it had negative revenue of $1.1 million and a net loss of $2.1 million, and it burned $6.0 million of cash over the last year. At the 2026-08-31 close of $2.87, the price does not look supported by the current numbers.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-08-31 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer